Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bitubol is a nutritional supplement developed by Amvia Biotech, available in both capsule and syrup formulations. The capsule formulation contains lycopene combined with a blend of antioxidants, while the syrup formulation consists of lycopene, a multivitamin complex, and alpha-tocopherol (Vitamin E). It is primarily indicated for providing antioxidant support and general micronutrient supplementation. Lycopene, a naturally occurring carotenoid, acts as a potent antioxidant that helps neutralize free radicals, thereby reducing oxidative stress and supporting overall cellular health, cardiovascular function, and prostate health. The inclusion of multivitamins and alpha-tocopherol in the syrup formulation provides additional support for metabolic processes and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bitubol.